Circulating cathepsin-S levels correlate with GFR decline and sTNFR1 and sTNFR2 levels in mice and humans.

about

The Multifaceted Role of the Lysosomal Protease Cathepsins in Kidney Disease.Cathepsin S As an Inhibitor of Cardiovascular Inflammation and Calcification in Chronic Kidney Disease.

P2860

Q47171560-127C3C7D-EC86-40F8-AE7C-5317E24DF3F7 Q47696609-3DFE65A5-32C5-41E7-8EC0-1E4A9106F6EA

P2860

Circulating cathepsin-S levels correlate with GFR decline and sTNFR1 and sTNFR2 levels in mice and humans.

Item

http://www.wikidata.org/entity/Q38940277

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Circulating cathepsin-S levels ...... FR2 levels in mice and humans.

@en

type

Item

label

Circulating cathepsin-S levels ...... FR2 levels in mice and humans.

@en

prefLabel

Circulating cathepsin-S levels ...... FR2 levels in mice and humans.

@en

P1476

Circulating cathepsin-S levels ...... FR2 levels in mice and humans.

@en

P2093

Dominik Steubl

http://www.w3.org/2001/XMLSchema#string

Hans-Joachim Anders

http://www.w3.org/2001/XMLSchema#string

Lutz Renders

http://www.w3.org/2001/XMLSchema#string

Maia Tato

http://www.w3.org/2001/XMLSchema#string

Santhosh V Kumar

http://www.w3.org/2001/XMLSchema#string

Shrikant R Mulay

http://www.w3.org/2001/XMLSchema#string

Uwe Heemann

http://www.w3.org/2001/XMLSchema#string

P2860

Inflammatory mediators regulate cathepsin S in macrophages and microglia: A role in attenuating heparan sulfate interactions

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

Cathepsin S required for normal MHC class II peptide loading and germinal center development

Deficiency of cathepsin S attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice

Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle?

Soluble TNF receptors and kidney dysfunction in the elderly.

Oxalate-induced chronic kidney disease with its uremic and cardiovascular complications in C57BL/6 mice.

Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline.

Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice

Estimating glomerular filtration rate from serum creatinine and cystatin C.

P2888

srep43538

P304

43538

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP43538

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-02-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1084131462

http://www.w3.org/2001/XMLSchema#string

P698

28240259

http://www.w3.org/2001/XMLSchema#string

P932

5327444

http://www.w3.org/2001/XMLSchema#string

Circulating cathepsin-S levels correlate with GFR decline and sTNFR1 and sTNFR2 levels in mice and humans.

about

P2860

P2860

Circulating cathepsin-S levels correlate with GFR decline and sTNFR1 and sTNFR2 levels in mice and humans.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P932